Adamax Pen

ADAMAX is a synthetic peptide analogue derived from the Semax peptide backbone, incorporating N-terminal acetylation and a C-terminal adamantyl group. These structural modifications are documented in research literature for their impact on molecular stability and resistance to enzymatic degradation.

ADAMAX (N-acetyl Semax-adamantyl) is a modified peptide referenced in biochemical and neuroscience research. It is structurally related to Semax, with the addition of an adamantyl group, which alters its physicochemical properties, including lipophilicity and stability.

Chemical reference information: CAS number: Not assigned (synthetic analogue); Molecular formula: C₂₂H₅₂N₁₆O₆; Molecular weight: 1032.24 g/mol. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

Adamax 10 mg is offered as a NORVEXA research pen. The selected strength refers to the compound content of this pen reference. Request the matching batch record for identity, analytical specifications, and presentation details.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

CAS number

Not assigned (synthetic analogue)

Molecular formula

C₂₂H₅₂N₁₆O₆

Molecular weight

1032.24 g/mol

Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.